Publication | Open Access
Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial
61
Citations
10
References
2021
Year
Difamilast 0·3% and 1% ointments are superior to vehicle and well tolerated in Japanese paediatric patients with AD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1